Bio-Techne (TECH) CEO Kim Kelderman Exercises Awards; Shares Withheld

What Happened Kim Kelderman, CEO of Bio-Techne (TECH), exercised/converted a package of stock awards on 2026-08-15. The filing reports 21,470 shares acquired by exercise/conversion and a total of 96,158 shares surrendered or otherwise disposed to the issuer in connection with the transaction. Of those, 10,821 shares were withheld to cover tax liability at $72.40 per share, valued at $783,440. Most other dispositions reported at $0 were company-side settlements (withholdings/surrenders/forfeitures), not open-market sales.

Key Details

• Transaction date: 2026-08-15; Form 4 filed: 2026-08-18 (appears timely).
• Prices reported: most conversions/exercises listed at $0 (award settlement); tax withholding shares priced at $72.40 (10,821 shares → $783,440).
• Shares: 21,470 shares acquired; 96,158 shares disposed/surrendered/withheld (net change reported by filing not shown as total ownership after transaction).
• Footnotes of note: several awards were performance-based and the Board authorized discretionary vesting for limited amounts while the remainder were forfeited (see F3, F4, F7, F8). RSUs represent contingent rights to one share (F2). Multiple awards have scheduled vesting in later years (see F10–F15).
• Transaction codes explained: M = exercise/conversion of derivative; F = payment/withholding for tax liability; D = disposition to issuer. These dispositions largely reflect internal settlement (withholding/forfeiture), not open-market selling.

Context This filing reflects exercises/conversions and company-side settlements (including tax withholding), not an open-market sale. Withholding or surrender of shares to cover taxes or satisfy exercise/settlement is routine and does not necessarily indicate a change in the insider’s market view.